Similar articles

• Improved immunosuppression with combination tacrolimus (FK506) and mycophenolic acid in orthotopic liver transplantation.

  Cai TH, Esterl RM Jr, Nichols L, Cigarroa F, Speeg KV, Halff GA. Cai TH, et al. Transplant Proc. 1998 Jun;30(4):1413-4. doi: 10.1016/s0041-1345(98)00295-4. Transplant Proc. 1998. PMID: 9636572 No abstract available.
• Rapamycin-based rescue therapy after chronic rejection in a pediatric liver transplant patient.

  Iglesias J, Ortega J, López JA, Sánchez L, Allende E, Asensio M, Margarit C. Iglesias J, et al. Transpl Int. 2003 Oct;16(10):765-7. doi: 10.1007/s00147-003-0608-0. Epub 2003 Jun 24. Transpl Int. 2003. PMID: 12827229 No abstract available.
• Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus.

  Daly I, Jain A, Reyes J, Fung J. Daly I, et al. Transplant Proc. 2002 Aug;34(5):1503. doi: 10.1016/s0041-1345(02)02948-2. Transplant Proc. 2002. PMID: 12176458 No abstract available.
• Immunosuppression and modulation in liver transplantation.

  Encke J, Uhl W, Stremmel W, Sauer P. Encke J, et al. Nephrol Dial Transplant. 2004 Jul;19 Suppl 4:iv22-5. doi: 10.1093/ndt/gfh1037. Nephrol Dial Transplant. 2004. PMID: 15240845 Review.
• Mycophenolate mofetil as induction therapy after liver transplantation.

  McDiarmid SV. McDiarmid SV. Liver Transpl Surg. 1999 Jul;5(4 Suppl 1):S85-9. doi: 10.1053/JTLS005s00085. Liver Transpl Surg. 1999. PMID: 10431021 Review. No abstract available.